Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)

The summary for the Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional): This limited competition Funding Opportunity Announcement (FOA) seeks an application from the current Sickle Africa Data Coordinating Center (SADaCC) to continue support of the activities of the renewed and expanded Sickle Pan-African Research Consortium (SPARCO), including the clinical coordinating center (CCC) in Tanzania, the 3 established sites in Ghana, Nigeria and Tanzania (and additional satellite sites), as well as up to 3 new Consortium sites located in additional sub-Saharan African nations. Together, these entities will constitute the Sickle Cell Disease (SCD) in Sub-Saharan Africa (SSA) Network. This network aims to develop a sustainable resource that will advance SCD-related epidemiologic, translational, and clinical research studies. The SADaCC application needs to propose a feasible and meritorious plan to provide overall project coordination, administration, data management, and biostatistical support of the SCD in SSA Network. In particular, this FOA seeks an application that plans for effective integration of SADaCC activities with those of SPARCO, the Consortium Sites, NHLBI, and review/monitoring bodies.

Federal Grant Title:	Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-21-008
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.839
CFDA Descriptions:	Information not provided
Current Application Deadline:	June 8th, 2020
Original Application Deadline:	June 8th, 2020
Posted Date:	March 12th, 2020
Creation Date:	March 12th, 2020
Archive Date:	July 14th, 2020
Total Program Funding:	$999,000
Maximum Federal Grant Award:	$925,000
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	March 12th, 2020

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-21-008.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immu...; • New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional); • Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (...; • Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional); • BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia ...; • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders; • Clinical Hematology Research Career Development Program (K12); • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...